Page last updated: 2024-09-03

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and E coli Infections

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with E coli Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, K; Mitsuyama, M; Nomoto, K; Ogawa, H; Osada, Y; Otani, T; Une, T1
Matsumoto, K; Mitsuyama, M; Nomoto, K; Ogawa, H; Osada, Y; Otani, T; Satoh, M; Une, T1

Other Studies

2 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and E coli Infections

ArticleYear
Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
    Infection and immunity, 1982, Volume: 37, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aging; Animals; Candidiasis; Escherichia coli Infections; Immunity, Innate; Immunosuppression Therapy; Male; Mice

1982
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
    Infection and immunity, 1982, Volume: 37, Issue:1

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Drug Synergism; Escherichia coli Infections; Glycopeptides; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Listeria monocytogenes; Listeriosis; Male; Mice; Phagocytosis; Staphylococcal Infections

1982